시장보고서
상품코드
1955399

유전체 시퀀싱 시장 보고서(2026년)

Genome Sequencing Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

유전체 시퀀싱 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 117억 8,000만 달러에서 2026년에는 140억 4,000만 달러로, CAGR 19.2%로 성장할 것으로 예상됩니다. 지금까지의 성장은 고급 시퀀싱 시스템의 공급이 제한적이었던 점, 전통적인 싱거법 시퀀싱에 대한 의존도, 유전체 연구 이니셔티브의 확대, 유전체 프로젝트에 대한 정부 자금의 증가, 맞춤형 의료에 대한 인식의 증가 등이 요인으로 보입니다.

유전체 시퀀싱 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 280억 7,000만 달러에 달하고, CAGR은 18.9%를 기록할 전망입니다. 예측 기간 동안의 성장은 차세대 시퀀싱 시스템 개발, 바이오인포매틱스 플랫폼의 확대, 정밀의료 프로그램 도입 증가, 생명공학 기업과 제약 기업 간의 협력 강화, 유전체 데이터 저장 및 관리 솔루션의 성장에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 차세대 염기서열 분석(NGS) 기술 채택 확대, 정밀의료 및 맞춤 치료에 대한 수요 증가, 바이오인포매틱스 및 데이터 분석 서비스 확대, 환경 및 마이크로바이옴 유전체학 응용 분야 성장, 연구용 맞춤형 유전체 분석 솔루션의 통합 등이 있습니다. 맞춤형 유전체 시퀀싱 솔루션의 통합 등을 꼽을 수 있습니다.

암 발생률의 증가는 향후 몇 년 동안 유전체 시퀀싱 시장의 성장을 견인할 것으로 예상됩니다. 암은 비정상적인 세포의 통제할 수 없는 증식과 확산을 특징으로 하는 질병군으로, 치료하지 않으면 생명을 위협할 수 있습니다. 암 발생률 증가에는 고령화, 생활습관, 환경노출, 유전적 소인 등의 요인이 영향을 미치고 있습니다. 유전체 염기서열 분석은 유전자 변이 및 유전적 소인을 파악하여 암 관리를 지원하고, 조기 발견 및 개인별 맞춤 치료 계획을 수립할 수 있도록 돕습니다. 또한, 유전성 암 위험도 평가 및 암세포의 진행 모니터링에도 도움이 됩니다. 예를 들어, 2024년 2월 스위스에 본부를 둔 국제기구인 세계보건기구(WHO)가 발표한 예측에 따르면, 신규 암 발병 건수는 2022년 2,000만 건에서 77% 증가하여 2050년까지 3,500만 건을 넘어설 것으로 예상됩니다. 따라서 암 유병률의 증가는 유전체 시퀀싱 시장의 확대에 기여하고 있습니다.

유전체 시퀀싱 시장에서 사업을 전개하는 주요 기업들은 차세대 염기서열분석(NGS) 기반 검사법 등 첨단 기술 개발에 주력하며 유전자 분석의 정확도 향상과 맞춤형 의료를 촉진하고 있습니다. 차세대염기서열분석(NGS) 기반 검사법은 DNA와 RNA의 신속한 염기서열분석을 가능하게 하는 고처리량 유전체 기술로 유전물질의 상세한 분석을 가능하게 합니다. NGS는 수백만 개의 DNA 또는 RNA 단편을 동시에 시퀀싱할 수 있으며, 효율적이고 비용 효율적인 방식으로 대량의 데이터를 생성할 수 있습니다. 예를 들어, 2023년 4월 독일에 본사를 둔 희귀질환 유전자 진단 업체인 Centogene N.V.는 첨단 NGS 기반 검사법 'CentoGenome'을 발표했습니다. CentoGenome은 추가 비용 없이 적극적인 진단 확인 및 재분류 프로그램을 통해 평생 진단 지원을 제공하여 지속적인 환자 관리와 정확한 질병 관리를 보장합니다. PCR-free 방식을 채택한 본 플랫폼은 바이어스를 최소화하여 시퀀싱 품질을 향상시키고, 분석이 어려운 유전체 영역의 커버리지를 높임과 동시에 코딩 영역, 조절 영역, 인트론 영역에 대한 지식을 심화시킵니다. 또한, 자동화된 바이오인포매틱스 파이프라인과 전문적인 의학 분석을 통합하고, 120여 개국, 약 70만 명의 환자 데이터를 보유한 CENTOGENE의 광범위한 바이오 데이터베이스를 활용하고 있습니다. 이 종합적인 데이터세트는 척수성 근위축증 및 파킨슨병과 관련된 돌연변이를 포함한 질병 원인 돌연변이의 검출 정확도를 향상시킵니다.

자주 묻는 질문

  • 유전체 시퀀싱 시장 규모는 어떻게 변화하고 있나요?
  • 유전체 시퀀싱 시장의 성장은 어떤 요인에 기인하나요?
  • 유전체 시퀀싱 시장에서 암 발생률의 증가는 어떤 영향을 미치나요?
  • 유전체 시퀀싱 시장에서 주요 기업들은 어떤 기술에 주력하고 있나요?
  • Centogene N.V.의 NGS 기반 검사법은 어떤 특징이 있나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM 26.03.25

Genome sequencing is the process of determining an organism's complete DNA sequence. It involves identifying the exact order of nucleotides-adenine, cytosine, guanine, and thymine-across the genome, which encompasses all of an organism's genetic material. Genome sequencing provides detailed insights into the genetic blueprint of an organism, allowing scientists to study genetic variations, detect mutations, and explore the relationships between genes and traits or diseases.

The main types of genome sequencing products include consumables, systems, software, and services. Consumables are single-use items required for DNA sample preparation, reaction facilitation, and sequencing data capture, ensuring accuracy and efficiency throughout the sequencing process. These products employ technologies such as polymerase chain reaction (PCR), sequencing, microarray, nucleic acid extraction, purification, and others, and are applied across areas including diagnostics, drug discovery, precision medicine, environmental genomics, research, and more. They are utilized by various end users, including hospitals and clinics, biotechnology and pharmaceutical companies, contract research organizations (CROs), government and research centers, academic institutions, and other facilities.

Tariffs have influenced the genome sequencing market by increasing costs for imported sequencing systems, reagents, consumables, and bioinformatics software. Segments such as NGS systems, sequencing chips, and library preparation kits are most affected, particularly in North America, Europe, and Asia-Pacific regions including China and India. This has led to higher operational costs and potential delays in research and diagnostic applications. On the positive side, tariffs have incentivized local manufacturing, domestic R&D investments, and the development of cost-efficient sequencing solutions.

The genome sequencing market research report is one of a series of new reports from The Business Research Company that provides genome sequencing market statistics, including genome sequencing industry global market size, regional shares, competitors with a genome sequencing market share, detailed genome sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the genome sequencing industry. This genome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genome sequencing market size has grown rapidly in recent years. It will grow from $11.78 billion in 2025 to $14.04 billion in 2026 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to limited availability of advanced sequencing systems, reliance on conventional sanger sequencing, growing genomics research initiatives, increasing government funding for genome projects, rising awareness of personalized medicine.

The genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $28.07 billion in 2030 at a compound annual growth rate (CAGR) of 18.9%. The growth in the forecast period can be attributed to development of next-generation sequencing systems, expansion of bioinformatics platforms, increasing adoption of precision medicine programs, rising collaborations between biotech and pharmaceutical companies, growth in genomic data storage and management solutions. Major trends in the forecast period include increasing adoption of next-generation sequencing (ngs) technologies, rising demand for precision medicine and personalized therapies, expansion of bioinformatics and data analysis services, growth in environmental and microbiome genomics applications, integration of custom genome sequencing solutions in research.

The rising incidence of cancer is expected to drive the growth of the genome sequencing market in the coming years. Cancer comprises a group of diseases characterized by uncontrolled growth and spread of abnormal cells, which can become life-threatening if not treated. The increasing occurrence of cancer is influenced by factors such as aging populations, lifestyle habits, environmental exposures, and genetic susceptibility. Genome sequencing supports cancer management by identifying genetic mutations and inherited predispositions, enabling early detection and the development of personalized treatment plans. It also helps assess inherited cancer risks and monitor the progression of cancerous cells. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, new cancer cases are projected to exceed 35 million by 2050, reflecting a 77% increase from 20 million cases in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the genome sequencing market.

Key companies operating in the genome sequencing market are focusing on developing advanced technologies, such as next-generation sequencing (NGS)-based assays, to improve the accuracy of genetic analysis and facilitate personalized medicine. Next-generation sequencing (NGS)-based assays are high-throughput genomic technologies that allow rapid sequencing of DNA or RNA, enabling detailed analysis of genetic material. NGS can sequence millions of DNA or RNA fragments simultaneously, generating large volumes of data efficiently and cost-effectively. For instance, in April 2023, Centogene N.V., a Germany-based provider of genetic diagnostics for rare diseases, launched CentoGenome, an advanced NGS-based assay. CentoGenome offers lifelong diagnostic support through proactive diagnosis confirmation and reclassification programs at no additional cost, ensuring continuous patient care and accurate disease management. Using a PCR-free approach, the platform minimizes bias and enhances sequencing quality, providing improved coverage of challenging genomic regions and better insights into coding, regulatory, and intronic areas. It also integrates an automated bioinformatics pipeline with expert medical analysis, leveraging CENTOGENE's extensive bio databank of approximately 700,000 patients across more than 120 countries. This comprehensive dataset enhances the detection of disease-causing variants, including those linked to spinal muscular atrophy and Parkinson's disease.

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies for research, acquired Verogen Inc. for an undisclosed amount. This acquisition allows QIAGEN to offer a full range of integrated forensic solutions using PCR, digital PCR, and NGS technologies, while also securing exclusive distribution rights. Verogen Inc. is a US-based provider of next-generation sequencing (NGS) solutions for forensic genomics.

Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMerieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics

North America was the largest region in the genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genome sequencing market consists of revenues earned by entities by providing services such as whole genome sequencing, targeted sequencing, and agri-genomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The genome sequencing market also includes sales of reagents, automated pipettors, and genotyping kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genome Sequencing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses genome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genome sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Consumables; Systems And Software; Services
  • 2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Microarray; Nucleic Acid Extraction; Purification; Other Technologies
  • 3) By Applications: Diagnostics; Drug Discovery; Precision Medicine; Environmental Genomics; Research; Other Applications
  • 4) By End-User: Hospitals And Clinics; Biotechnology And Pharmaceutical Companies; Contract Research Organizations (CROs); Government; Research Centers; Academic And Government Institutes; Other End-Users
  • Subsegments:
  • 1) By Consumables: Reagents And Kits; Sequencing Chips And Plates; Sample Preparation Products; Library Preparation Kits; DNA And RNA Extraction Kits
  • 2) By Systems And Software: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Bioinformatics Software And Analysis Tools; Data Management And Storage Solutions; Laboratory Information Management Systems (LIMS)
  • 3) By Services: Sequencing Services; Bioinformatics Analysis Services; Consultation And Support Services; Custom Genome Sequencing Solutions; Sample Collection And Preparation Services.
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Eurofins Genomics; Agilent Technologies Inc.; PerkinElmer; Illumina Inc.; bioMerieux; Bio-Rad Laboratories Inc.; QIAGEN N.V.; 10x Genomics Inc.; BGI Group; Oxford Nanopore Technologies plc; Pacific Biosciences of California Inc.; GENEWIZ Inc.; LI-COR Inc.; CENTOGENE N.V.; Bioneer Corporation; Strand Life Sciences Pvt Ltd.; Nebula Genomics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Genome Sequencing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Genome Sequencing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Genome Sequencing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Genome Sequencing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Next-Generation Sequencing (Ngs) Technologies
    • 4.2.2 Rising Demand For Precision Medicine And Personalized Therapies
    • 4.2.3 Expansion Of Bioinformatics And Data Analysis Services
    • 4.2.4 Growth In Environmental And Microbiome Genomics Applications
    • 4.2.5 Integration Of Custom Genome Sequencing Solutions In Research

5. Genome Sequencing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Biotechnology And Pharmaceutical Companies
  • 5.3 Contract Research Organizations (Cros)
  • 5.4 Research Centers
  • 5.5 Academic And Government Institutes

6. Genome Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Genome Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Genome Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Genome Sequencing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Genome Sequencing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Genome Sequencing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Genome Sequencing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Genome Sequencing Market Segmentation

  • 9.1. Global Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Systems And Software, Services
  • 9.2. Global Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction, Purification, Other Technologies
  • 9.3. Global Genome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Other Applications
  • 9.4. Global Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Biotechnology And Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic And Government Institutes, Other End-Users
  • 9.5. Global Genome Sequencing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Kits, Sequencing Chips And Plates, Sample Preparation Products, Library Preparation Kits, DNA And RNA Extraction Kits
  • 9.6. Global Genome Sequencing Market, Sub-Segmentation Of Systems And Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Bioinformatics Software And Analysis Tools, Data Management And Storage Solutions, Laboratory Information Management Systems (LIMS)
  • 9.7. Global Genome Sequencing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sequencing Services, Bioinformatics Analysis Services, Consultation And Support Services, Custom Genome Sequencing Solutions, Sample Collection And Preparation Services

10. Genome Sequencing Market Regional And Country Analysis

  • 10.1. Global Genome Sequencing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Genome Sequencing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Genome Sequencing Market

  • 11.1. Asia-Pacific Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Genome Sequencing Market

  • 12.1. China Genome Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Genome Sequencing Market

  • 13.1. India Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Genome Sequencing Market

  • 14.1. Japan Genome Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Genome Sequencing Market

  • 15.1. Australia Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Genome Sequencing Market

  • 16.1. Indonesia Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Genome Sequencing Market

  • 17.1. South Korea Genome Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Genome Sequencing Market

  • 18.1. Taiwan Genome Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Genome Sequencing Market

  • 19.1. South East Asia Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Genome Sequencing Market

  • 20.1. Western Europe Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Genome Sequencing Market

  • 21.1. UK Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Genome Sequencing Market

  • 22.1. Germany Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Genome Sequencing Market

  • 23.1. France Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Genome Sequencing Market

  • 24.1. Italy Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Genome Sequencing Market

  • 25.1. Spain Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Genome Sequencing Market

  • 26.1. Eastern Europe Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Genome Sequencing Market

  • 27.1. Russia Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Genome Sequencing Market

  • 28.1. North America Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Genome Sequencing Market

  • 29.1. USA Genome Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Genome Sequencing Market

  • 30.1. Canada Genome Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Genome Sequencing Market

  • 31.1. South America Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Genome Sequencing Market

  • 32.1. Brazil Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Genome Sequencing Market

  • 33.1. Middle East Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Genome Sequencing Market

  • 34.1. Africa Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Genome Sequencing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Genome Sequencing Market Regulatory and Investment Landscape

36. Genome Sequencing Market Competitive Landscape And Company Profiles

  • 36.1. Genome Sequencing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Genome Sequencing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Genome Sequencing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Genome Sequencing Market Other Major And Innovative Companies

  • Siemens Healthineers, Becton Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMerieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc.

38. Global Genome Sequencing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Genome Sequencing Market

40. Genome Sequencing Market High Potential Countries, Segments and Strategies

  • 40.1 Genome Sequencing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Genome Sequencing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Genome Sequencing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제